Retatrutide targets three natural hormones ( GLP-1 , GIP , glucagon ) instead of one, and early data show bariatric-level weight loss without surgery
glabrata cells were resuspended in sterile saline and adjusted to 5 10 8 or 1 10 9 cells/ml
Understanding The Science Behind the Medication Semaglutide, a glucagon-like peptide-1 (GLP-1) analog, is mainly used to treat type 2 diabetes
Development of a first-in-class unimolecular dual GIP/GLP-2 analogue, GL-0001, for the treatment of bone fragility
Semaglutide does cause a small increase in resting heart rate (24 beats per minute on average), which should be monitored but rarely requires intervention
The journey from discovery to approval is worth dwelling on because it illustrates how counterintuitive pharmacological breakthroughs can be